Effects of Roflumilast on Patients with Chronic Obstructive Pulmonary Disease Treated with Inhaled Corticosteroid/Long-Acting β2 Agonist: A Meta-analysis

OBJECTIVE: Roflumilast is a novel therapeutic drug for chronic obstructive pulmonary disease (COPD). This study was designed to evaluate the efficacy and safety of roflumilast combining inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) in treating COPD patients through the meta-analysis. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Shasha, Bai, Haibing, Zou, Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338846/
https://www.ncbi.nlm.nih.gov/pubmed/35915771
http://dx.doi.org/10.1155/2022/8101099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338846/
https://www.ncbi.nlm.nih.gov/pubmed/35915771
http://dx.doi.org/10.1155/2022/8101099

Ejemplares similares